Related Experiment Videos
Correction of Duncan's syndrome by allogeneic bone marrow transplantation
L L Williams1, C M Rooney, M E Conley
1Department of Hematology/Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
Lancet (London, England)
|September 4, 1993
Abstract:
Duncan's syndrome (X-linked lymphoproliferative disorder) is a fatal immunodeficiency syndrome of unknown aetiology and without cure. We show that allogeneic bone marrow transplantation can correct the lethal immune deficits in a patient with this syndrome. We suggest that the primary abnormality in Duncan's syndrome is in bone-marrow derived cells.